Absolutely. A $75M market cap is ridiculously low for the pipeline we have already established. This doesn't even count pending Prurisol results. Once we strike a deal and get cash in the bank we should get a more realistic valuation. That will lead to up list and institutional buying which should help catapult us skyward.
Also note that AXON and CTSO are on NASDAQ which naturally supports a higher valuation. I don't like mentioning NNVC in the same post as IPIX...frustrates me that they have a higher market cap and none of the pipeline success that we have.
Go IPIX!
(2)
(2)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.